Atossa Genetics Reports First Quarter 2013 Results and Operating Highlights
15 mai 2013 08h30 HE
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - May 15, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced its first quarter 2013 financial results and corporate...
Atossa Genetics to Exhibit at American Congress of Obstetrics and Gynecology Meeting
29 avr. 2013 08h30 HE
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Apr 29, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, will display its ForeCYTE Breast Health Test at the 61st Annual Clinical Meeting...
Atossa Genetics to Present at FSX San Francisco Investor Conference
23 avr. 2013 08h00 HE
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Apr 23, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, CFO and General Counsel, will present the...
Atossa Genetics to Provide ForeCYTE Breast Health Test to Two Leading Breast Centers in Texas
16 avr. 2013 08h30 HE
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Apr 16, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, will soon begin providing its patented ForeCYTE Breast Health Test for early...
Atossa Genetics Launches Nationwide Awareness Program for Breast Cancer Prevention Test
15 avr. 2013 08h30 HE
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Apr 15, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, today announced the launch of a new National Awareness Program, including a video...
Atossa Genetics to Present at the FSX Dallas Investor Conference
05 févr. 2013 14h09 HE
|
Atossa Genetics
SEATTLE, WA--(Marketwire - Feb 5, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, CFO and General Counsel, will present...
Atossa Genetics to Present at the 15th Annual BIO CEO and Investor Conference
28 janv. 2013 08h15 HE
|
Atossa Genetics
SEATTLE, WA--(Marketwire - Jan 28, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Dr. Steven C. Quay, M.D., Ph.D., FCAP, Chairman, CEO and...
Atossa Genetics, Inc. to Present at the Personalized Medicine World Conference in Mountain View, California
17 janv. 2013 08h00 HE
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Jan 17, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that Steven C. Quay, M.D., Ph.D., FCAP, Chairman, CEO and President of Atossa, will make two...
Atossa Genetics and Clarity Women's Health Announce U.S. Launch of the ForeCYTE Breast Health Test
14 janv. 2013 08h00 HE
|
Atossa Genetics, Inc.
BOCA RATON, FL--(Marketwire - Jan 14, 2013) - Atossa Genetics (NASDAQ: ATOS), the Breast Health Company™, based in Seattle, Washington, and Clarity Women's Health (a division of Diagnostic...
Christopher S. Destro Joins Atossa Genetics as Vice President of Sales and Marketing
21 déc. 2012 08h30 HE
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Dec 21, 2012) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Christopher S. Destro has joined the Company as Vice...